State Street’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,243,571
| Closed | -$133M | – | 4771 |
|
|
2023
Q1 | $133M | Sell |
1,243,571
-104,609
| -8% | -$11.2M | 0.01% | 1006 |
|
|
2022
Q4 | $148M | Sell |
1,348,180
-237,894
| -15% | -$26.2M | 0.01% | 921 |
|
|
2022
Q3 | $93.6M | Buy |
1,586,074
+1,100,857
| +227% | +$65M | 0.01% | 1143 |
|
|
2022
Q2 | $13.7M | Sell |
485,217
-502,243
| -51% | -$14.2M | ﹤0.01% | 2503 |
|
|
2022
Q1 | $37.3M | Buy |
987,460
+546,100
| +124% | +$20.6M | ﹤0.01% | 1937 |
|
|
2021
Q4 | $17.5M | Buy |
441,360
+244,094
| +124% | +$9.65M | ﹤0.01% | 2569 |
|
|
2021
Q3 | $4.68M | Buy |
197,266
+41,465
| +27% | +$983K | ﹤0.01% | 3272 |
|
|
2021
Q2 | $3.83M | Buy |
+155,801
| New | +$3.83M | ﹤0.01% | 3360 |
|